Literature DB >> 30305944

Electrical disorders in atrial septal defect: genetics and heritability.

Hisaaki Aoki1, Minoru Horie2.   

Abstract

Atrial septal defect (ASD) is one of the most common types of congenital heart diseases (CHDs). Most ASDs occur sporadically, but some are inherited and associated with cardiac conduction defects such as atrioventricular block (AVB) or bundle branch block. Mutations in genes encoding transcription factor gene TBX5 and NKX2-5, were found in Holt-Oram syndrome (HOS) and ASD with atrioventricular (AV) conduction defects, respectively. HOS is characterized by upper limb anomaly in addition to ASD and AVB (heart-hand syndrome). ASD associated with NKX2-5 is rare but is reported to cause sudden cardiac death (SCD) or cardiomyopathy. We provide a review of these two diseases.

Entities:  

Keywords:  Atrial septal defect (ASD); Holt-Oram syndrome (HOS); NKX2-5; TBX5; atrioventricular block (AVB); genetics

Year:  2018        PMID: 30305944      PMCID: PMC6174139          DOI: 10.21037/jtd.2018.02.53

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  55 in total

1.  T-box transcription factor Tbx2 represses differentiation and formation of the cardiac chambers.

Authors:  Vincent M Christoffels; Willem M H Hoogaars; Alessandra Tessari; Danielle E W Clout; Antoon F M Moorman; Marina Campione
Journal:  Dev Dyn       Date:  2004-04       Impact factor: 3.780

2.  Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.

Authors:  Kayoko Hirayama-Yamada; Mitsuhiro Kamisago; Kaoru Akimoto; Hiroyuki Aotsuka; Yoshihide Nakamura; Hideshi Tomita; Michiko Furutani; Shin-ichiro Imamura; Atsuyoshi Takao; Makoto Nakazawa; Rumiko Matsuoka
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

3.  Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects.

Authors:  Maoqing Ye; Fabienne Parente; Xiaodong Li; M Benjamin Perryman; Leopoldo Zelante; Anthony Wynshaw-Boris; Ju Chen; Paul Grossfeld
Journal:  Am J Med Genet A       Date:  2014-03-10       Impact factor: 2.802

4.  Skeletal manifestations of the Holt-Oram syndrome.

Authors:  A K Poznanski; J C Gall; A M Stern
Journal:  Radiology       Date:  1970-01       Impact factor: 11.105

5.  Assignment of cardiac homeobox gene CSX to human chromosome 5q34.

Authors:  I Shiojima; I Komuro; J Inazawa; Y Nakahori; I Matsushita; T Abe; R Nagai; Y Yazaki
Journal:  Genomics       Date:  1995-05-01       Impact factor: 5.736

Review 6.  T-box genes in human disorders.

Authors:  Elizabeth A Packham; J David Brook
Journal:  Hum Mol Genet       Date:  2003-04-01       Impact factor: 6.150

7.  Prevalence and spectrum of NKX2.5 mutations in patients with congenital atrial septal defect and atrioventricular block.

Authors:  Ying-Jia Xu; Xing-Biao Qiu; Fang Yuan; Hong-Yu Shi; Lei Xu; Xu-Min Hou; Xin-Kai Qu; Xu Liu; Ri-Tai Huang; Song Xue; Yi-Qing Yang; Ruo-Gu Li
Journal:  Mol Med Rep       Date:  2017-02-24       Impact factor: 2.952

8.  Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development.

Authors:  Zachary Harrelson; Robert G Kelly; Sarah N Goldin; Jeremy J Gibson-Brown; Roni J Bollag; Lee M Silver; Virginia E Papaioannou
Journal:  Development       Date:  2004-10       Impact factor: 6.868

9.  Holt-Oram syndrome: a clinical genetic study.

Authors:  R A Newbury-Ecob; R Leanage; J A Raeburn; I D Young
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

Review 10.  Familial Atrial Septal Defect and Sudden Cardiac Death: Identification of a Novel NKX2-5 Mutation and a Review of the Literature.

Authors:  Sabrina Gade Ellesøe; Morten Munk Johansen; Jesper Vandborg Bjerre; Vibeke Elisabeth Hjortdal; Søren Brunak; Lars Allan Larsen
Journal:  Congenit Heart Dis       Date:  2015-12-18       Impact factor: 2.007

View more
  1 in total

1.  Functional analysis of two novel TBX5 variants present in individuals with Holt-Oram syndrome with different clinical manifestations.

Authors:  Débora Varela; Tatiana Varela; Natércia Conceição; Ângela Ferreira; Nuno Marques; Ana Paula Silva; Pedro Azevedo; Salomé Pereira; Ana Camacho; Ilídio de Jesus; M Leonor Cancela
Journal:  Mol Genet Genomics       Date:  2021-04-17       Impact factor: 3.291

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.